CMR myocardial tissue characterization in a mouse model of doxorubicin-induced cardiotoxicity

被引:0
|
作者
Bradley D Allen
Micah Anderle
Sol Misener
Gillian Murtagh
Nicholas Furiasse
Nausheen Akhter
Daniele Procissi
James C Carr
机构
[1] Northwestern University,Radiology
[2] Northwestern University,Medicine
关键词
Gadopentetate Dimeglumine; Inversion Recovery Sequence; Cardiac Function Deterioration; Variable Flip Angle; Left Ventricular Base;
D O I
10.1186/1532-429X-17-S1-Q135
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity
    Cove-Smith, Laura
    Woodhouse, Neil
    Hargreaves, Adam
    Kirk, Jason
    Smith, Susan
    Price, Sally A.
    Galvin, Melanie
    Betts, Catherine J.
    Brocklehurst, Simon
    Backen, Alison
    Radford, John
    Linton, Kim
    Roberts, Ruth A.
    Schmitt, Matthias
    Dive, Caroline
    Tugwood, Jonathan D.
    Hockings, Paul D.
    Mellor, Howard R.
    TOXICOLOGICAL SCIENCES, 2014, 140 (01) : 3 - 15
  • [42] Early detection of doxorubicin-induced myocardial damage by ultrasound tissue characterization with integrated backscatter
    Yokoyama, N
    Takeshita, S
    Kozuma, K
    Nishimura, H
    Chikuda, I
    Terakura, M
    Kawamura, Y
    Suzuki, M
    Isshiki, T
    CIRCULATION JOURNAL, 2003, 67 (11) : 929 - 933
  • [43] Doxorubicin-induced cardiotoxicity is associated with a change in high density lipoprotein subclasses in a mouse breast cancer model
    Byrne, Nikole J.
    Witt, Constantin N.
    Koentges, Christoph
    Pfeil, Katharina
    Pusdrowski, Thomas
    Gollmer, Johannes
    Vosko, Ivan
    Bode, Christoph
    Zirlik, Andreas
    Bugger, Heiko
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S67 - S67
  • [44] Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
    Liu, Hao
    Wang, Haiyan
    Xiang, Dingcheng
    Guo, Wangang
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (01) : 44 - 50
  • [45] Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
    Lin, Xiaoxiao
    Wu, Guomin
    Wang, Shuai
    Huang, Jinyu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
    Kuang, Ziyu
    Wu, Jingyuan
    Tan, Ying
    Zhu, Guanghui
    Li, Jie
    Wu, Min
    BIOMOLECULES, 2023, 13 (03)
  • [47] Protectors against doxorubicin-induced cardiotoxicity: Flavonoids
    A. Bast
    H. Kaiserová
    G. J. M. den Hartog
    G. R. M. M. Haenen
    W. J. F. van der Vijgh1
    Cell Biology and Toxicology, 2007, 23 : 39 - 47
  • [48] Liposomal doxorubicin-induced cardiotoxicity - case report
    Chmielowska, Ewa
    Kwiatkowski, Mariusz
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (03): : 152 - 156
  • [49] Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat
    Hole, Lisa Drange
    Larsen, Terje Hjalmar
    Fossan, Kjell Ove
    Lime, Fredrik
    Schjott, Jan
    CARDIOVASCULAR TOXICOLOGY, 2014, 14 (03) : 251 - 259
  • [50] Identification of the molecular basis of doxorubicin-induced cardiotoxicity
    Sui Zhang
    Xiaobing Liu
    Tasneem Bawa-Khalfe
    Long-Sheng Lu
    Yi Lisa Lyu
    Leroy F Liu
    Edward T H Yeh
    Nature Medicine, 2012, 18 : 1639 - 1642